|
Sign In to gain access to subscriptions and/or personal tools.
|
Can the Expanded Disability Status Scale be assessed by telephone?
J Lechner-Scott
Department of Neurology, Kantonspital Basel, Switzerland, Department of Medicine, John Hunter Hospital, Newcastle, Australia
L Kappos
Department of Neurology, Kantonspital Basel, Switzerland, lkappos{at}uhbs.ch
M Hofman
Department of Neurology, Kantonspital Basel, Switzerland
C H Polman
Department of Neurology, University Hospital, Amsterdam, Netherlands
H Ronner
Department of Neurology, University Hospital, Amsterdam, Netherlands
X Montalban
Department of Neurology, Ciudad Sanitaria Vall d'Hebron, Barcelona, Spain
M Tintore
Department of Neurology, Ciudad Sanitaria Vall d'Hebron, Barcelona, Spain
M Frontoni
Clinica Neurologica de l'Università Rome, Rome, Italy
C Buttinelli
Clinica Neurologica de l'Università Rome, Rome, Italy
M P Amato
Department of Neurological and Psychiatric Sciences, University of Florence, Italy
M L Bartolozzi
Department of Neurological and Psychiatric Sciences, University of Florence, Italy
M Versavel
Klinische Entwicklung Schering, Germany
F Dahlke
Klinische Entwicklung Schering, Germany
J-F Kapp
Klinische Entwicklung Schering, Germany
R Gibberd
Department of Statistics, University of Newcastle, Newcastle, Australia
Information from patients who are unable to continue their visits to a study centre may be of major importance for the interpretatio n of results in multiple sclerosis (MS) clinical trials. To validate a questionnaire based on the Expanded Disability Status Scale (EDSS), patients in five different European centres were assessed independently by pairs of trained EDSS raters, first by telepho ne interview and a few days later by standardized neurological examination. Seventy women and 40 men with an average age of 43.7 years (range 19 -74 years) were included in the study. Mean EDSS score at the last visit was 4.5 (0 -9). EDSS assessment by telepho ne was highly correlated with the EDSS determined by physical examination (Pearsons correlation coefficient -0.95). A n intraclass correlation coefficient (IC C) of 94.8% was found for the total sample; 77.6% and 86%, respectively, for patients with EDSSB-4.5 (n -46) and \-4.5 (n -64). Kappa values for full agreement were 0.48; for variation by -0.5 steps and -1.0 steps, 0.79 and 0.90, respectively. Best agreement could be found in higher EDSS scores, where assessment by telepho ne interview might be needed most. The telepho ne questionnaire is a valid tool to assess EDSS score in cases where the patient is unable to continue visiting a study centre or in long-term follow-up of trial participants.
Key Words: assessment clinical scale multiple sclerosis
Multiple Sclerosis, Vol. 9, No. 2,
154-159 (2003)
DOI: 10.1191/1352458503ms884oa

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Boggild, J. Palace, P. Barton, Y. Ben-Shlomo, T. Bregenzer, C. Dobson, and R. Gray
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator
BMJ,
December 2, 2009;
339(dec02_1):
b4677 - b4677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Minneboo, B. Uitdehaag, P Jongen, H Vrenken, D. Knol, M. van Walderveen, C. Polman, J. Castelijns, and F Barkhof
Association between MRI parameters and the MS severity scale: a 12 year follow-up study
Multiple Sclerosis,
May 1, 2009;
15(5):
632 - 637.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Tallantyre, L. Bo, O. Al-Rawashdeh, T. Owens, C. H. Polman, J. Lowe, and N. Evangelou
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
Brain,
May 1, 2009;
132(5):
1190 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Swanton, K. T. Fernando, C. M. Dalton, K. A. Miszkiel, D. R. Altmann, G. T. Plant, A. J. Thompson, and D. H. Miller
Early MRI in optic neuritis: The risk for disability
Neurology,
February 10, 2009;
72(6):
542 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Costelloe, A Thompson, C Walsh, N Tubridy, and M Hutchinson
Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease
J. Neurol. Neurosurg. Psychiatry,
November 1, 2008;
79(11):
1245 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Khaleeli, D. R. Altmann, M. Cercignani, O. Ciccarelli, D. H. Miller, and A. J. Thompson
Magnetization Transfer Ratio in Gray Matter: A Potential Surrogate Marker for Progression in Early Primary Progressive Multiple Sclerosis
Arch Neurol,
November 1, 2008;
65(11):
1454 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Fisniku, P. A. Brex, D. R. Altmann, K. A. Miszkiel, C. E. Benton, R. Lanyon, A. J. Thompson, and D. H. Miller
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
Brain,
March 1, 2008;
131(3):
808 - 817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.A. Marrie and M. Goldman
Validity of performance scales for disability assessment in multiple sclerosis
Multiple Sclerosis,
November 1, 2007;
13(9):
1176 - 1182.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L Lopatinskaya, J Zwemmer, B Uitdehaag, K Lucas, C Polman, and L Nagelkerken
Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years
Multiple Sclerosis,
November 1, 2006;
12(6):
704 - 709.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Agosta, M. Rovaris, E. Pagani, M. P. Sormani, G. Comi, and M. Filippi
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis
Brain,
October 1, 2006;
129(10):
2620 - 2627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kappos, A. Traboulsee, C. Constantinescu, J. -P. Eralinna, F. Forrestal, P. Jongen, J. Pollard, M. Sandberg-Wollheim, C. Sindic, B. Stubinski, et al.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Neurology,
September 26, 2006;
67(6):
944 - 953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S J Pittock, R L McClelland, S J Achenbach, F Konig, A Bitsch, W Bruck, H Lassmann, J E Parisi, B W Scheithauer, M Rodriguez, et al.
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease
J. Neurol. Neurosurg. Psychiatry,
December 1, 2005;
76(12):
1693 - 1697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A.J. Visschedijk, B. M.J. Uitdehaag, M. Klein, E. van der Ploeg, E. H. Collette, L. Vleugels, L. E.M.A. Pfennings, E. L.J. Hoogervorst, H. M. van der Ploeg, and C. H. Polman
Value of health-related quality of life to predict disability course in multiple sclerosis
Neurology,
December 14, 2004;
63(11):
2046 - 2050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Pittock, W. T. Mayr, R. L. McClelland, N. W. Jorgensen, S. D. Weigand, J. H. Noseworthy, and M. Rodriguez
Disability profile of MS did not change over 10 years in a population-based prevalence cohort
Neurology,
February 24, 2004;
62(4):
601 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Ingle, V. L. Stevenson, D. H. Miller, and A. J. Thompson
Primary progressive multiple sclerosis: a 5-year clinical and MR study
Brain,
November 1, 2003;
126(11):
2528 - 2536.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|